AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis
Completed · Phase 2
Conditions studied: Psoriasis
In brief
The purpose of this study is to determine whether AN2728 topical ointment is a safe and effective treatment for mild-to-moderate plaque-type psoriasis.
Key facts
- Study ID
- NCT01300052
- Run by
- Pfizer
- People needed
- 68
- Starts
- 2011-01-26
- Expected to finish
- 2011-06-06
- Last updated by the study team
- 2017-04-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of stable mild-to-moderate plaque-type psoriasis involving 2-35% of total body surface area (BSA) excluding face, scalp, and genitals
- Willingness and ability to apply study medication as directed, comply with study instructions, and commit to attending all study visits
- Women of childbearing potential must agree to use contraception for the entire study period
You may not qualify if…
- Any dermatological conditions that could interfere with clinical evaluations
- Concurrent or recent use of certain topical or systemic medications without a sufficient washout period
- Significant confounding conditions as assessed by study doctor
- Participated in any other trial of an investigational drug within 30 days or participation in a research study concurrent with this study
- Use of lithium- or hydroxychloroquine-containing products (e.g., Plaquenil)
- Use of a beta-blocking medication (e.g., propranolol) if the dose has not been stabilized for at least 3 months
- Pregnancy or lactation
Where it is running
- The Savin Center — New Haven, Connecticut, United States
- Dermatology Specialists, PSC — Louisville, Kentucky, United States
- Minnesota Clinical Study Center — Fridley, Minnesota, United States
- Karl G. Heine, MD Dermatology — Henderson, Nevada, United States
- Academic Dermatology Associates — Albuquerque, New Mexico, United States
- Dermatology Consulting Services — High Point, North Carolina, United States
- Oregon Medical Research Center — Portland, Oregon, United States
- DermResearch, Inc — Austin, Texas, United States
- J&S Studies, Inc. — College Station, Texas, United States
- The Center for Skin Research — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.